BioPartners Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
1
BioPartners General Information
Description
Owner and operator of a biotechnology company, primarily focusing on the development of drugs and bio-pharmaceuticals. The company's main products include: Valtropin, Interferon beta, Alpheon and Ravanex.
Contact Information
Website
www.biopartners.chCorporate Office
- Sihlbruggstrasse 3
- 6340 Baar
- Switzerland
Corporate Office
- Sihlbruggstrasse 3
- 6340 Baar
- Switzerland
BioPartners Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioPartners Patents
BioPartners Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20050123612-A1 | Hepatitis c-virus (hcv); reduced waste | Inactive | 21-Dec-2001 | ||
| ES-2238497-T3 | Ribavirine granulate for the obtaining of filmed tablets. | Inactive | 21-Dec-2001 | ||
| FR-2697645-B1 | Method and device for reducing the water consumption of photographic film developing machines. | Inactive | 30-Oct-1992 | ||
| FR-2697645-A1 | Reduced water usage in photographic development - by addn. of biocide, dispersant and surfactant to washing tank and glycolic enzyme to overflow pipe | Active | 30-Oct-1992 | ||
| FR-2622206-A1 | Biological composition for cleaning discharges from equipment for developing photographic films and radiographic films | Active | 27-Oct-1987 | G03C11/005 |
BioPartners Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BioPartners Investments (1)
BioPartners’s most recent deal was a Early Stage VC with MagnaMedics. The deal was made on 01-Dec-2004.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MagnaMedics | 01-Dec-2004 | Early Stage VC | Biotechnology |
BioPartners Exits (1)
BioPartners’s most recent exit was on 01-Dec-2004 from MagnaMedics. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| MagnaMedics | 01-Dec-2004 | Completed |
|
BioPartners FAQs
-
When was BioPartners founded?
BioPartners was founded in 2000.
-
Where is BioPartners headquartered?
BioPartners is headquartered in Baar, Switzerland.
-
What industry is BioPartners in?
BioPartners’s primary industry is Biotechnology.
-
Is BioPartners a private or public company?
BioPartners is a Private company.
-
What is the current valuation of BioPartners?
The current valuation of BioPartners is .
-
What is BioPartners’s current revenue?
The current revenue for BioPartners is .
-
Who are BioPartners’s investors?
Global Healthcare Partners and aPriori Capital Partners have invested in BioPartners.
-
When was BioPartners acquired?
BioPartners was acquired on 09-Mar-2007.
-
Who acquired BioPartners?
BioPartners was acquired by Bioton.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process